The Medicare drug price negotiation program could improve coverage of drugs selected for negotiation for Medicare beneficiaries because the law requires all Medicare Part D plans to cover each of the selected drugs, including all dosages and forms, when negotiated prices take effect. This analysis examines 2026 Medicare Part D formulary coverage of drugs selected…
On January 1, 2026, the Center for Medicare & Medicaid Innovation (CMMI) launched the Wasteful and Inappropriate Service Reduction (WISeR) Model that establishes new prior authorization requirements in traditional Medicare. This analysis explores the potential impact of the WISeR model by examining recent spending and utilization trends in traditional Medicare for services selected for prior…
This interactive tool tracks public opinion on the Affordable Care Act, from the inception of the law to the present. It highlights key moments when views shifted and trends based on party identification, income, age, gender, and race/ethnicity.
This issue brief explains why it can be misleading to compare the first year of Rural Health Transformation Program allocations with estimated Medicaid cuts, which will be implemented on a gradual basis and not fully take effect until 2027, after the rural health fund is exhausted.
Weeks after the Trump administration reduced the number of childhood vaccine recommended for routine use, public trust in the CDC is at its lowest since the COVID-19 pandemic, and less than half are confident in federal agencies’ ability to make such recommendations. Among those who have heard about the revised recommendations, more say they expect…
In the weeks after the Trump administration reduced the number of recommended childhood vaccines for routine use, the public’s trust in the CDC remains at its lowest point. Among those who have heard about the recent changes to the recommended childhood vaccine schedule, more say they expect the changes to have a negative impact than…
The post Calcium IV Drips: The Modern Solution for Stronger Bones appeared first on Medifyhome.
This issue brief provides an overview of the H-1B visa program, analyzes trends in H-1B visa approvals for the health care and social assistance industries using data from the U.S. Citizenship and Immigration Services, and discusses potential implications of recent policies impacting the H-1B program on the U.S. health care workforce.
This brief explains the limitations of early data in understanding the impact of the expiration of enhanced premiums tax credit on ACA enrollment. It also provides a timeline of when more complete data will become available.
New KFF polling explores the challenges beyond costs that people with insurance face in navigating the health care system. People cite prior authorization review as their top problem by a wide margin, with a third (32%) saying prior authorization requirements are a “major burden.